Technical Analysis for LLY - Eli Lilly and Company

Grade Last Price % Change Price Change
grade A 128.3 -0.03% -0.04
LLY closed down 0.03 percent on Friday, March 22, 2019, on 79 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical LLY trend table...

Date Alert Name Type % Chg
Mar 22 MACD Bullish Signal Line Cross Bullish 0.00%
Mar 21 Up 3 Days in a Row Strength -0.03%
Mar 21 Up 4 Days in a Row Strength -0.03%
Mar 21 Up 5 Days in a Row Strength -0.03%
Mar 20 Calm After Storm Range Contraction 0.11%
Mar 20 Gapped Up Strength 0.11%
Mar 20 Up 3 Days in a Row Strength 0.11%
Mar 20 Up 4 Days in a Row Strength 0.11%
Mar 19 20 DMA Support Bullish 1.35%
Mar 19 Up 3 Days in a Row Strength 1.35%

Older signals for LLY ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company's neuroscience products treat major depressive disorders; schizophrenia, acute mixed or manic episodes associated with bipolar I disorder, and bipolar maintenance; attention-deficit hyperactivity disorder; depressive disorder, obsessive-compulsive disorder, bulimia nervosa, and panic disorder; bipolar depression and treatment-resistant depression; and brain imaging of beta-amyloid plaques. Its endocrinology products treat diabetes; osteoporosis in postmenopausal women and men at high risk of fracture; human growth hormone deficiency and pediatric growth conditions; and testosterone deficiency. The company's oncology products treat malignant pleural mesothelioma; pancreatic, metastatic breast, non-small cell lung, ovarian, bladder, colorectal, and head and neck cancers, as well as cardiovascular products, which are used treat erectile dysfunction, benign prostatic hyperplasia, high cholesterol, pulmonary arterial hypertension; reduce thrombotic cardiovascular events; and used as adjunct to percutaneous coronary intervention. In addition, it provides animal health products, such as cattle feed additives; antibiotics to treat respiratory and other diseases in cattle, swine, and poultry; leanness and performance enhancers for swine and cattle; protein supplements to improve milk productivity in dairy cows; anticoccidial agents; antibiotics to control enteric infections in calves and swine; products to treat canine separation anxiety; products that prevent flea infestations on dogs, kills fleas, prevent heartworm disease, and control intestinal parasite infections; and other pharmaceutical products to treat staphylococcal and bacterial infections. The company distributes its products through independent wholesale distributors; and directly to pharmacies. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Diabetes Pharmaceutical Products Neuroscience Schizophrenia Antibiotics Pulmonary Arterial Hypertension Animal Health Products Depression Psychiatry Psychiatric Diagnosis Attention Deficit Hyperactivity Disorder Major Depressive Disorder Wholesale Distributors Benign Prostatic Hyperplasia Bipolar Disorder Osteoporosis Cardiovascular Products Depressive Disorder Obsessive Compulsive Disorder Erectile Dysfunction Head And Neck Cancers Major Depressive Disorders Oncology Products Bulimia Nervosa High Cholesterol Psychology Testosterone Deficiency Treatment Resistant Depression
Is LLY a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 130.75
52 Week Low 74.65
Average Volume 19,374,329
200-Day Moving Average 108.2551
50-Day Moving Average 121.5914
20-Day Moving Average 126.0
10-Day Moving Average 125.496
Average True Range 2.5825
ADX 32.93
+DI 33.6458
-DI 12.1821
Chandelier Exit (Long, 3 ATRs ) 123.0025
Chandelier Exit (Short, 3 ATRs ) 129.5475
Upper Bollinger Band 129.7157
Lower Bollinger Band 122.2843
Percent B (%b) 0.81
BandWidth 5.897937
MACD Line 1.5744
MACD Signal Line 1.5324
MACD Histogram 0.042
Fundamentals Value
Market Cap 135.35 Billion
Num Shares 1.05 Billion
EPS 2.31
Price-to-Earnings (P/E) Ratio 55.54
Price-to-Sales 4.03
Price-to-Book 6.30
PEG Ratio 1.77
Dividend 2.08
Dividend Yield 1.62%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 131.38
Resistance 3 (R3) 131.43 130.45 130.86
Resistance 2 (R2) 130.45 129.67 130.43 130.69
Resistance 1 (R1) 129.38 129.19 128.89 129.33 130.52
Pivot Point 128.40 128.40 128.16 128.38 128.40
Support 1 (S1) 127.33 127.62 126.84 127.28 126.08
Support 2 (S2) 126.35 127.14 126.33 125.91
Support 3 (S3) 125.28 126.35 125.74
Support 4 (S4) 125.23